Enduring Activity: Clinical Updates in Alzheimer's Disease and Related Dementia Symposium –
Alzheimer’s Disease Updates
Target Audience
This activity is designed for physicians, physician assistants, advanced practice providers, nurses, and other allied health care professionals.
Statement of Need
Memory issues can often be overlooked in primary care unless reported by patients, leading to delayed dementia diagnosis and treatment. This activity will help providers recognize dementia as a complex condition, identify its types and symptoms, explore management options, and understand the importance of interdisciplinary teams and referrals.
With over 55 million people worldwide living with dementia, addressing these gaps is crucial for improving patient outcomes.
Objectives
At the conclusion of this offering, the participant will be able to:
Describe the diagnosis of Alzheimer's Disease with biomarker confirmation.
Identify treatment goals and potential side effects of antiamyloid therapies.
Faculty
Gregory E. Cooper, M.D., Ph.D.
Chief, Adult Neurology
Medical Director, Memory Center
Norton Neuroscience Institute
Faculty Disclosure
The speaker, Gregory Cooper, M.D., PhD, has the following relationships with ineligible companies to disclose: Eli Lilly, as a principal investigator of anti-amyloid therapies; Eisai as a principal investigator of anti-amyloid therapies. These relationships have been successfully mitigated.
Planner & Moderator Disclosure
The following planners of this activity have relevant relationships with ineligible companies to disclose:
Rachel Hart, D.O.: Eli Lilly, faculty on speaker’s bureau for Neuroscience – Kisunla.
Gregory Cooper, M.D., PhD: Eli Lilly, as a principal investigator of anti-amyloid therapies; Eisai as a principal investigator of anti-amyloid therapies.
These relationships have been successfully mitigated.
The other planners and moderators of this activity have no relevant relationships with ineligible companies to disclose.
Commercial Support
This activity has not received commercial support.
Accreditation
Norton Healthcare is accredited by the Kentucky Medical Association to provide continuing medical education for physicians.
Designation
Norton Healthcare designates this enduring activity for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Credits
Norton Healthcare Institute for Education & Development is approved as a provider of nursing continuing professional development by the South Carolina Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. This continuing professional development activity has been approved for 0.75 contact hours. In order for nursing participants to obtain credits, they must claim attendance by attesting to the number of hours in attendance.
For more information related to nursing credits, contact Sally Sturgeon, DNP, RN, SANE-A, AFN-BC at (502) 446-5889 or sally.sturgeon@nortonhealthcare.org.
Date of Original Release | July 13, 2025
Course Termination Date | July 2027
Contact Information | Center for Continuing Medical Education; (502) 446-5955 or cme@nortonhealthcare.org
Evaluation
https://www.surveymonkey.com/r/Alzhei...
Resources
Информация по комментариям в разработке